Baxdela Intravenous and Rucaparib Camsylate
Determining the interaction of Baxdela Intravenous and Rucaparib Camsylate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Rucaparib may increase the blood levels and effects of delafloxacin. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with rucaparib may increase the plasma concentrations and the risk of adverse effects of drugs that are substrates of breast cancer resistance protein (BCRP) (e.g., rosuvastatin) and/or uridine diphosphate glucuronosyltransferase (UGT) 1A1 (e.g., deferasirox). The proposed mechanism, based on in vitro data, is decreased clearance due to rucaparib-mediated inhibition of these transport proteins.
MANAGEMENT: Caution is advised if rucaparib is used with drugs that are substrates of BCRP and/or UGT1A1, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring should be considered whenever rucaparib is added to or withdrawn from therapy with these drugs. Patients should be monitored for the development of adverse effects.
- EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000366.jsp&mid=WC0b01ac058067c852" ([2013 - ]):
Generic Name: delafloxacin
Brand name: Baxdela
Synonyms: Baxdela
Generic Name: rucaparib
Brand name: Rubraca
Synonyms: Rucaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Baxdela Intravenous-Ruconest
- Baxdela Intravenous-Rufinamide
- Baxdela Intravenous-Rufinamide Oral Suspension
- Baxdela Intravenous-Rufinamide Tablets
- Baxdela Intravenous-Rulox
- Baxdela Intravenous-Rum-K
- Rucaparib Camsylate-Baycadron
- Rucaparib Camsylate-Baycadron Elixer
- Rucaparib Camsylate-Baycol
- Rucaparib Camsylate-Bayer
- Rucaparib Camsylate-Bayer Back & Body
- Rucaparib Camsylate-Bayer Back & Body Pain Extra Strength